Unfortunately, the nuclear disasters in Chernobyl and Fukushima have shown us just how catastrophic radiation can be. But what if there was a way to intervene in the 24 hours after radiation exposure, limiting damage to the human body? Researchers are optimistic that they’ve discovered a promising treatment.
Normally, radiation exposure affects the integrity of the intestines, which can lead to radiation-induced gastrointestinal syndrome (RIGS). There is no cure for RIGS, but now, there might be a way to prevent it. But by administering a compound (DMOG) that blocks certain proteins, researchers found that in mice, tissues were modified in a way that allowed them to repair and regenerate.
A potential treatment for those exposed to radiation is really good news. The survival rate in mice was greatly increased after this therapy, and there’s a possibility that this could also have an impact on patients receiving radiation during cancer treatments. While it’s too early to tell whether or not cancer patients could benefit from this drug, the good news is that it’s already in clinical trials to treat a blood disorder, so safety assessments are already in the works. Read more about the research here: